may thought i nothing say arise rd study risperidone risperdal used adjunctive add treatment depression incredibly information pertinent discussion already familiar issues surrounding authorship paper please skip ahead two paragraphs may recall authorship altered study presented abstract form presented american college neuropsychopharmacology conference published final form neuropsychopharmacology i took exception keller big name psychiatry added paper author appear previous abstract author i hypothesized keller added big name gives study air scientific credibility especially given study unimpressive results clear use statistical legerdemain adding big name excellent marketing ploy janssen quote earlier piece authorship paper keller get study keller credited study concept design i would deem impossible since really conceived designed study would appeared author earlier abstract yet listed fourth list people designed study also credited along authors analysis interpretation data critical revision manuscript important intellectual content possible great job helping revise manuscript i suppose seems plenty people also involved writing paper note keller credited drafting manuscript keller recruit participants provided administrative support provide statistical expertise draft manuscript apparently helped design study completed impressive indeed point post i tracked study presented previously two three occasions outside acnp conference presented american psychiatric association conference possibly two different forms though i sure point well american psychiatric association conference ncdeu conference see page ncdeu reference american psychiatric association references keller nemeroff conspicuously absent apa ncdeu presentations yet appear final manuscript authors nemeroff appears lead author acnp abstract study despite appearing prior presentations keller allegedly helped design study appears final manuscript appears single presentation study data top press release touted keller nemeroff co principal investigators study obviously really principal investigators meaningful sense term names would appeared earlier presentations data additional research seemed keller contributions minimal best appears nemeroff work also called question appears nowhere earlier presentations prior acnp presentation point i would say evidence quite clear changing authorship paper little authors responsible conducting study running analyses writing paper sure makes excellent marketing big names like nemeroff keller stick names authorship line please feel free read entire story starting detailed description authorship saga followed covered conflicts interest finally tricky use statistics